Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 2421–2440 of 17,529 recalls

February 9, 2023· L. Perrigo Company

Recalled Item: Allergy ALLER-FEX

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2023· L. Perrigo Company

Recalled Item: aller-ease

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2023· HTO Nevada, Inc.

Recalled Item: Maximum Zone2 Topical Analgesic

The Issue: cGMP Deviation: Raw material recalled by repackager, due

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2023· HTO Nevada, Inc.

Recalled Item: New & Improved Blue Gel Anesthetic

The Issue: cGMP Deviation: Raw material recalled by repackager, due

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 8, 2023· Apollo Care

Recalled Item: Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to

The Issue: Lack of assurance of sterility: Suspected microbial growth

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 8, 2023· Dr. Reddy's Laboratories, Inc.

Recalled Item: Tacrolimus Capsules

The Issue: Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Tadalafil Tablets

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Aripiprazole Tablets

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Simvastatin Tablets USP 40 mg Rx Only

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Finasteride Tablets USP 1 mg

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Tadalafil Tablets

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Glycopyrrolate Injection

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: BusPIRone Hydrochloride Tablets USP 30 mg

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Atorvastatin Calcium Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Pravastatin Sodium Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Daptomycin for Injection 500 mg per vial

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Dofetilide Capsules 250 mcg (0.25 mg) 60-count bottle

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Atorvastatin Calcium Tablets USP 80 mg* Rx Only

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Montelukast Sodium Tablets

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Atorvastatin Calcium Tablets USP 40 mg* Rx Only

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund